| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Luteolin | AGE Products | 1 | PM | 33058977 | 📋 | Protective actions of bioactive flavonoids chrysin and luteolin on the glyoxal induced formation of advanced glycation end products and aggregation of human serum albumin: In vitro and molecular docking analysis |
| Luteolin | AGE Products | 3 | PM | 29108086 | 📋 | Anti-degenerative effect of Apigenin, Luteolin and Quercetin on human keratinocyte and chondrocyte cultures: SAR evaluation |
| Luteolin | AGE Products | 2 | PM | 19489629 | 📋 | Low-density-lipoprotein (LDL)-bound flavonoids increase the resistance of LDL to oxidation and glycation under pathophysiological concentrations of glucose in vitro |
| Luteolin | Diabetes Type 2 | 3 | PM | 37749346 | 📋 | Modulation of PPAR-γ, SREBP-1c and inflammatory mediators by luteolin ameliorates β-cell dysfunction and renal damage in a rat model of type-2 diabetes mellitus |
| Luteolin | Diabetes Type 2 | 2 | PM | 35215317 | 📋 | Magnolol and Luteolin Inhibition of α-Glucosidase Activity: Kinetics and Type of Interaction Detected by In Vitro and In Silico Studies |
| Luteolin | Diabetes Type 2 | 1 | PM | 34948468 | 📋 | Luteolin Improves Perivascular Adipose Tissue Profile and Vascular Dysfunction in Goto-Kakizaki Rats |
| Luteolin | Glucose Metabolism Disorder | 1 | PM | 33347668 | 📋 | Protection against Alzheimer's disease by luteolin: Role of brain glucose regulation, anti-inflammatory activity, and the gut microbiota-liver-brain axis |
| Luteolin | Hypercholesterolemia | 1 | PM | 32598492 | 📋 | Luteolin Improves Hypercholesterolemia and Glucose Intolerance Through LXRα-dependent Pathway in Diet-Induced Obese Mice |
| Luteolin | Hypercholesterolemia | 3 | PM | 31590417 | 📋 | The Effect of Polyphenols on Hypercholesterolemia through Inhibiting the Transport and Expression of Niemann-Pick C1-Like 1 |
| Luteolin | Hypercholesterolemia | 2 | PM | 29671020 | 📋 | Luteolin alleviates cardiac ischemia/reperfusion injury in the hypercholesterolemic rat via activating Akt/Nrf2 signaling |
| Luteolin | Hypercholesterolemia | 4 | PM | 29198743 | 📋 | Apigenin and luteolin display differential hypocholesterolemic mechanisms in mice fed a high-fat diet |
| Luteolin | Hyperglycemia | 2 | PM | 35322626 | 📋 | Meta-analysis Flavonoids from traditional Chinese herbs for diabetes in rats: a network Meta-analysi |
| Luteolin | Hyperglycemia | 1 | PM | 28650731 | 📋 | Combination Treatments with Luteolin and Fisetin Enhance Anti-Inflammatory Effects in High Glucose-Treated THP-1 Cells Through Histone Acetyltransferase/Histone Deacetylase Regulation |
| Luteolin | Hyperlipidemia | 3 | PM | 37408924 | 📋 | Luteolin reduces cardiac damage caused by hyperlipidemia in Sprague-Dawley rats |
| Luteolin | Hyperlipidemia | 2 | PM | 36147301 | 📋 | The hypolipidemic mechanism of chrysanthemum flavonoids and its main components, luteolin and luteoloside, based on the gene expression profile |
| Luteolin | Hyperlipidemia | 1 | PM | 34439559 | 📋 | Hypolipidemic Effects and Preliminary Mechanism of Chrysanthemum Flavonoids, Its Main Components Luteolin and Luteoloside in Hyperlipidemia Rats |
| Luteolin | Insulin Resistance | 4 | PM | 33900851 | 📋 | Luteolin alleviates polycystic ovary syndrome in rats by resolving insulin resistance and oxidative stress |
| Luteolin | Insulin Resistance | 2 | PM | 31302373 | 📋 | Luteolin reduces adipose tissue macrophage inflammation and insulin resistance in postmenopausal obese mice |
| Luteolin | Insulin Resistance | 1 | PM | 30282902 | 📋 | Luteolin Targets the Toll-Like Receptor Signaling Pathway in Prevention of Hepatic and Adipocyte Fibrosis and Insulin Resistance in Diet-Induced Obese Mice |
| Luteolin | Insulin Resistance | 3 | PM | 19954946 | 📋 | Luteolin enhances insulin sensitivity via activation of PPARγ transcriptional activity in adipocytes |
| Luteolin | Metabolic Disorders | 2 | PM | 33522240 | 📋 | Dietary Luteolin: A Narrative Review Focusing on Its Pharmacokinetic Properties and Effects on Glycolipid Metabolism |
| Luteolin | Metabolic Disorders | 1 | PM | 33135040 | 📋 | Luteolin cooperated with metformin hydrochloride alleviates lipid metabolism disorders and optimizes intestinal flora compositions of high-fat diet mice |
| Luteolin | Metabolic Endotoxemia | 1 | PM | 32419296 | 📋 | Switch Off "Parallel Circuit": Insight of New Strategy of Simultaneously Suppressing Canonical and Noncanonical Inflammation Activation in Endotoxemic Mice |
| Luteolin | Metabolic Syndrome | 1 | PM | 31731527 | 📋 | Altilix ® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study |
| Luteolin | Metabolic Syndrome | 2 | PM | 30060507 | 📋 | Luteolin-Enriched Artichoke Leaf Extract Alleviates the Metabolic Syndrome in Mice with High-Fat Diet-Induced Obesity |
| Luteolin | Mitochondrial Dysfunction | 2 | PM | 33761951 | 📋 | Neuronal cell-based high-throughput screen for enhancers of mitochondrial function reveals luteolin as a modulator of mitochondria-endoplasmic reticulum coupling |
| Luteolin | Mitochondrial Dysfunction | 1 | PM | 32402583 | 📋 | Protective Effects of Luteolin Against Oxidative Stress and Mitochondrial Dysfunction in Endothelial Cells |
| Luteolin | Obesity | 11 | PM | 36760156 | 📋 | Diet Supplementation of Luteolin Before Fatty Liver Formation Improves Hepatic Steatosis in Obese Mice by Inhibiting Visceral Adipose Tissue Lipolysis |
| Luteolin | Obesity | 10 | PM | 36370929 | 📋 | The activity comparison of six dietary flavonoids identifies that luteolin inhibits 3T3-L1 adipocyte differentiation through reducing ROS generation |
| Luteolin | Obesity | 9 | PM | 36300856 | 📋 | Nutritional activities of luteolin in obesity and associated metabolic diseases: an eye on adipose tissues |
| Luteolin | Obesity | 8 | PM | 36076880 | 📋 | Peanut Shell Extract and Luteolin Regulate Lipid Metabolism and Induce Browning in 3T3-L1 Adipocytes |
| Luteolin | Obesity | 6 | PM | 33379198 | 📋 | IFNγ is a Key Link between Obesity and Th1-Mediated AutoImmune Diseases |
| Luteolin | Obesity | 12 | PM | 33003339 | 📋 | Plasma Lipidomics Reveals Insights into Anti-Obesity Effect of Chrysanthemum morifolium Ramat Leaves and Its Constituent Luteolin in High-Fat Diet-Induced Dyslipidemic Mice |
| Luteolin | Obesity | 1 | PM | 32598492 | 📋 | Luteolin Improves Hypercholesterolemia and Glucose Intolerance Through LXRα-dependent Pathway in Diet-Induced Obese Mice |
| Luteolin | Obesity | 7 | PM | 31912839 | 📋 | Luteolin reduces fat storage in Caenorhabditis elegans by promoting the central serotonin pathway |
| Luteolin | Obesity | 5 | PM | 31302373 | 📋 | Luteolin reduces adipose tissue macrophage inflammation and insulin resistance in postmenopausal obese mice |
| Luteolin | Obesity | 4 | PM | 30319424 | 📋 | Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity |
| Luteolin | Obesity | 3 | PM | 30282902 | 📋 | Luteolin Targets the Toll-Like Receptor Signaling Pathway in Prevention of Hepatic and Adipocyte Fibrosis and Insulin Resistance in Diet-Induced Obese Mice |
| Luteolin | Obesity | 2 | PM | 30060507 | 📋 | Luteolin-Enriched Artichoke Leaf Extract Alleviates the Metabolic Syndrome in Mice with High-Fat Diet-Induced Obesity |
